Designing the Most Effective Clinical Trials for TGF-β Targeted Therapies Toward Clinical Efficacy
Time: 9:01 am
day: Pre-Conference Day
Details:
Taking the TGF-β targeted therapies to the clinic has proven difficult to show efficacy. In the light of clinical failures such as bintrafusp alfa, this workshop will deep dive into the best clinical trial design by reviewing the data and overcoming the bottlenecks to help lead the most efficacious TGF-β targeted therapies towards clincial success.
This workshop will cover:
- What is the best conduct and formulation of clinical trials for TGF-β targeted drugs?
- How do you identify the right patients to enroll in clinical trials?
- What challenges need to be overcome to improve for future clinical trial design?
